QQ客服 官方微博 反馈留言

	Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
	Tan, Wenyong[1,2]; Yang, Ming[3]; Yang, Hongli[2]; Zhou, Fangbin[2]; Shen, Weixi[1]
	2018
卷号	10页码:4333
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4604304
专题	暨南大学
作者单位	1.[1]Southern Med Univ, Dept Oncol, Shenzhen Hosp, Shenzhen, Peoples R China 2.[2]Jinan Univ, Clin Med Coll 2, Clin Med Res Ctr, Shenzhen People Hosp, Shenzhen, Peoples R China 3.[3]Shenzhen Jingmai Med Sci & Tech Co, Shenzhen, Peoples R China
推荐引用方式 GB/T 7714	Tan, Wenyong[1,2],Yang, Ming[3],Yang, Hongli[2],et al. Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers[J],2018,10:4333.
APA	Tan, Wenyong[1,2],Yang, Ming[3],Yang, Hongli[2],Zhou, Fangbin[2],&Shen, Weixi[1].(2018).Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.,10,4333.
MLA	Tan, Wenyong[1,2],et al."Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers".10(2018):4333.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。